Pathways’ Picks January 29: Coronavirus Dx, Next-Gen Coverage, EU Meetings, And More

article image

Medicare moves to clear up a next-generation sequencing coverage mix-up; the escalating coronavirus outbreak is driving attention toward diagnostic emergency-use approval policies in China and the US; EU policymakers issued a 2020 meeting agenda, and more in this week’s Pathways’ Picks, Market Pathways’ weekly roundup of the most important global medtech regulatory, reimbursement, and policy news. Pictured: A railway station in China's Wuhan Province, ground zero for the coronavirus.

The Centers for Medicare and Medicaid Services removed coverage restrictions on next-generation sequencing testing as a treatment guide in early-stage inherited cancers. Diagnostics are also increasingly a focus of governments trying to respond to the coronavirus outbreak. Those IVD policy developments lead off this week’s Pathways’ Picks.


This article is restricted to subscribers only.

Sign in to continue reading.


We're here to help! Please contact us at: